Case ReportCase Study
Risk-Based Approach for Analytical Comparability and Comparability Protocols
Kavita Ramalingam Iyer and Isabelle Lequeux
PDA Journal of Pharmaceutical Science and Technology September 2020, 74 (5) 563-570; DOI: https://doi.org/10.5731/pdajpst.2019.010439
Kavita Ramalingam Iyer
1RD Chief Regulatory Office, GSK; and
Isabelle Lequeux
2BioPhorum, E-mail:

References
- 1.↵International Conference for Harmonisation, Quality Guideline Q5E: Comparability of Biotechnological/Biological Products. ICH Geneva, 2005.
- 2.↵International Conference for Harmonisation, Quality Guideline Q6B: Specifications: Test Procedures and Acceptance Criteria for Biotechnological/Biological Products. ICH Geneva, 1999.
- 3.↵International Conference for Harmonisation, Quality Guideline Q5C: Stability Testing of Biotechnological/Biological Products. ICH Geneva, 1996.
- 4.↵International Conference for Harmonisation, Quality Guideline Q1A(R2): Stability Testing of New Drug Substances and Products. ICH Geneva, 2003.
- 5.↵International Conference for Harmonisation, Quality Guideline Q10: Pharmaceutical Quality System. ICH Geneva, 2008.
- 6.↵International Conference for Harmonisation, Quality Guideline Q11: Development and Manufacture of Drug Substances (Chemical Entities and Biotechnological/Biological Entities). ICH Geneva, 2013.
- 7.International Conference for Harmonisation, Quality Guideline Q9: Quality Risk Management. ICH Geneva, 2006.
In This Issue
PDA Journal of Pharmaceutical Science and Technology
Vol. 74, Issue 5
September/October 2020
Risk-Based Approach for Analytical Comparability and Comparability Protocols
Kavita Ramalingam Iyer, Isabelle Lequeux
PDA Journal of Pharmaceutical Science and Technology Sep 2020, 74 (5) 563-570; DOI: 10.5731/pdajpst.2019.010439
Jump to section
- Article
- Abstract
- 1. Introduction
- 2. Evaluation of the Impact of Postapproval Changes
- 3. Definition of Comparability
- 4. Elements of Analytical Comparability
- 5. Considerations for the Comparability Exercise
- 6. Concluding Remarks
- 7. Case Studies: Scientific Risk-Based Approach for Designing Analytical Comparability
- Conflict of Interest Declaration
- Acknowledgements
- Footnotes
- References
- Figures & Data
- References
- Info & Metrics
Related Articles
- No related articles found.